Israel-based diagnostics manufacturer MeMed has secured $93m in private financing, it announced January 10.
This latest financing brings the total raised by the company to over $200m. In the past, the company has also received support from the U
The company will use the money to fund its US commercialization strategy and continue to develop its host response-based product pipeline.
Israel-based diagnostics manufacturer MeMed has secured $93m in private financing, it announced January 10.
This latest financing brings the total raised by the company to over $200m. In the past, the company has also received support from the U